Viatris Inc.


Find Out if You Qualify for a Financial Reward by filling out the form below.

Viatris Inc. Form

Stock Fraud Law Center does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. (“Viatris” or the “Company”) (NasdaqGS: VTRS) concerning possible violations of federal securities laws.

Before the market opened on February 28, 2022, Viatris unexpectedly announced the Company had entered into an agreement to sell its biosimilars business to Biocon Biologics Limited, which was anticipated to close in the second half of 2022. Additionally, Viatris announced that it was seeking to divest additional business assets and undertaking a significant global reshaping of its business, which would focus on developing products in three core therapeutic areas: ophthalmology, gastrointestinal and dermatology. Viatris also announced lower-than expected guidance for fiscal year 2022 with total revenues expected to be between $17.0 to $17.5 billion, adjusted EBITDA expected to be $5.8 to $6.2 billion, and free cash flow expected to be $2.5 to $2.9 billion. Viatris attributed the lower-than expected guidance, in part, to competition around key products, price deterioration in certain markets, foreign exchange impacts, inflation, and a lower adjusted EBITDA margin for the biosimilar business due to its partnership structure and profit-sharing arrangements.

Following this news, Viatris’ stock price fell approximately 24% to close at $11.01 per share on February 28, 2022.

Active Cases

Ticker SymbolCompany NameJoin DeadlineJoin
MARAMarathon Digital Holdings, Inc.May 30, 2023Join
TALTAL Education GroupMay 30, 2023Join
TGTTarget CorporationMay 30, 2023Join
GWGHQGWG Holdings, Inc.June 02, 2023Join
MPWMedical Properties Trust, Inc.June 12, 2023Join
PLUGPlug Power Inc.June 12, 2023Join
TSETrinseo PLCJune 20, 2023Join
HBNCHorizon Bancorp, Inc.June 20, 2023Join
FRCFirst Republic BankJune 23, 2023Join
LPSNLivePerson, Inc.June 23, 2023Join
EGIOEdgio, Inc. f/k/a Limelight Networks, Inc.June 26, 2023Join
FULCFulcrum Therapeutics, Inc.June 27, 2023Join
ADDYYadidas AGJune 27, 2023Join
TDSTelephone and Data Systems, Inc.July 03, 2023Join
SPRSpirit AeroSystems Holdings, Inc.July 05, 2023Join
IEPIcahn Enterprises L.P.July 10, 2023Join
BYNDBeyond Meat, Inc.July 10, 2023Join
DISThe Walt Disney CompanyJuly 11, 2023Join
VTRSViatris Inc.July 14, 2023Join
VIRTVirtu Financial, Inc.July 18, 2023Join
CRLCharles River Laboratories International, Inc.July 18, 2023Join
FHNFirst Horizon CorporationJuly 21, 2023Join
VTRSViatris Inc.January 01, 2024Join